Cutera, the provider of aesthetic and dermatology solutions, has announced a change in leadership. In a recent dispute over succession planning, the company ousted its previous chief executive and executive chairman. Now, Cutera has appointed Taylor Harris, one of its newest board members, to take on the role of CEO starting August 7th.
Earlier this year, Cutera fired its former CEO, David Mowry, along with its executive chairman, Daniel Plants. Allegations were made that the pair had been attempting to seize control of the company following its decision to look for an external candidate to fill the CEO position. As a result, Sheila Hopkins, an independent board member, temporarily served as interim CEO while the company searched for a permanent replacement for Mowry.
Taylor Harris brings valuable experience to the role, having previously served as the chief financial officer of biopharmaceutical company MyoKardia until its acquisition by Bristol Myers Squibb in 2020. Despite taking on the CEO position, Harris will also continue to serve on the board, alongside Sheila Hopkins.
